Antibody Catalogue

Working With CRT

Testimonials

Licensing Portfolio

Small Molecules

Biological Therapeutics

Mouse & Cell Line Portfolio

CRT's Discovery Pipeline

Commercialisation Routes

Antibody Portfolio - R

Antigen	Clone
Rab11a	STo 2F3
Rab11a	Sto 7C10
Rad17	Rad17 1C6/2
Rad24	Polyclonal
RAD51C	MTA37
Rad51	Rad51 3C10
Rad51	Polyclonal SWE26
Rad51B	Rad51B 1E11/6
Rad51B	rad51b 1h3/13
Rad51C	Rad51C 2H11/6
Rad51C	polyclonal 3R68
Rad51D	Rad51D 5A8/4
Rad51D	Rad51D 5B3/6
Rad52	Polyclonal FBE3
Rad54	Rad54 4E3/1
RAET1E	119/6/17/2
RAET1E	79/6/13/16
RAET1E	50/3/2/2
RAP1	RAP1 4C8/1
RecA	Polyclonal SWE8
Respiratory Syncytial Virus M2-1 Protein	RSV5H5
Respiratory Syncytial Virus Phosphoprotein	RSVH102
Respiratory Syncytial Virus Phosphoprotein	RSV1C3
Respiratory Syncytial Virus Subgroup A G Glycoprotein	RSV133
Respiratory Syncytial Virus Subgroup A G Glycoprotein	RSV1C2
Respiratory Syncytial Virus Subgroup A G Glycoprotein	RSV5A6
Retinoblastoma (Rb1)	Rb1
RIP140	6D7
RNA pol II	CTD 4H8
RNA pol II (phospho)	CTD 8A7
Rough Endoplasmic Reticulum Component	BU18
RuvA	RuvA 12C6
RuvA	Polyclonal SWE2
RuvB	RuvB 4G5/1
RuvB	Polyclonal SWE4
RuvC	RuvC 5G9/3
RuvC	RuvC 7F1/5
RuvC	Polyclonal SWE6

For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information.